Response to: “Comment on Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”

• Simone Famularo, MD,
• Matteo Donadon, MD, PhD,
• Federica Cipriani, MD,
• Luca Aldrighetti, MD, PhD,
• Franco Trevisani, MD,
• Guido Torzilli, MD, PhD, FACS

Affiliations

Simone Famularo, MD

From the * Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy

Matteo Donadon, MD, PhD

‡ Department of Health Science, Università del Piemonte Orientale, Novara, Italy

Federica Cipriani, MD

‖ Hepatobiliary Surgery Division, IRCCS San Raffaele Scientific Institute, Milan, Italy

Luca Aldrighetti, MD, PhD

‖ Hepatobiliary Surgery Division, IRCCS San Raffaele Scientific Institute, Milan, Italy

Franco Trevisani, MD

¶ Unit of Semeiotics, Liver and Alcohol-related diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy

Guido Torzilli, MD, PhD, FACS

From the * Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy